Dr Leo Figgs, DO in Yakima, WA - Medicare Ophthalmology

Dr Leo Figgs, DO is a medicare enrolled "Ophthalmology" physician in Yakima, Washington. He went to Kansas City University Of Med & Biosciences, College Of Osteo Med and graduated in 1975 and has 49 years of diverse experience with area of expertise as Ophthalmology. He is a member of the group practice Yakima Eye Spcialists and his current practice location is 1410 Lakeside Ct Ste 103, Yakima, Washington. You can reach out to his office (for appointments etc.) via phone at (509) 453-2010.

Dr Leo Figgs is licensed to practice in Washington (license number OP00000819) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1841381746.

Contact Information

	Dr Leo Figgs, DO
	1410 Lakeside Ct Ste 103, Yakima, WA 98902-7305
	(509) 453-2010
	(509) 225-6420

Physician's Profile

Full Name	Dr Leo Figgs
Gender	Male
Speciality	Ophthalmology
Experience	49 Years
Location	1410 Lakeside Ct Ste 103, Yakima, Washington
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Leo Figgs attended and graduated from Kansas City University Of Med & Biosciences, College Of Osteo Med in 1975

NPI Data:

NPI Number: 1841381746
Provider Enumeration Date: 09/27/2006
Last Update Date: 07/08/2007

Medicare PECOS Information:

PECOS PAC ID: 8325944200
Enrollment ID: I20050829000832

Medical Identifiers

Medical identifiers for Dr Leo Figgs such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1841381746	NPI	-	NPPES
1498203	Medicaid	WA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207W00000X	Ophthalmology	OP00000819 (Washington)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Yakima Eye Spcialists	5092047399	3

News Archive

Data of ImmunoCellular's lead dendritic cell cancer vaccine candidate for GBM presented at AAN meeting

ImmunoCellular Therapeutics, Ltd., announced that Surasak Phuphanich, MD, Principal Investigator of the Phase I clinical trial of ImmunoCellular's lead dendritic cell cancer vaccine candidate for glioblastoma multiforme presented safety and preliminary efficacy data yesterday at the American Academy of Neurology 63rd Annual Meeting.

Caltech researchers develop new technique that increases safety of TCR gene therapy

The human body produces T cells to recognize and fight disease. Each T cell has a unique T cell receptor (or TCR) on its surface that surveils small fragments of proteins presented by other cells.

SIDS risk lowered by use of pacifier

The risk of Sudden Infant Death Syndrome (SIDS), the third leading cause of infant death, may be lowered through the use of a pacifier.

RRM2 may be a facilitating factor in colorectal cancer and UV-induced DNA damage repair

Colorectal cancer (CRC) is the leading cause of cancer-related death worldwide. In addition, the incidence and mortality rates of colorectal cancer are on the rise. Recently, metabolic genes have received increasing and specific attention due to their potential role in carcinogenesis.

Study offers hope of early detection, treatment of liver cancer

Liver cancer is the second leading cause of cancer-related mortality worldwide, claiming 700,000 lives each year. Most cases are discovered too late for a cure - but now a study offers hope of early detection, and targets for new treatments.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Leo Figgs allows following entities to bill medicare on his behalf.

Entity Name	Yakima Eye Spcialists
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1790349249 PECOS PAC ID: 5092047399 Enrollment ID: O20191105002066

News Archive

Data of ImmunoCellular's lead dendritic cell cancer vaccine candidate for GBM presented at AAN meeting

Caltech researchers develop new technique that increases safety of TCR gene therapy

The human body produces T cells to recognize and fight disease. Each T cell has a unique T cell receptor (or TCR) on its surface that surveils small fragments of proteins presented by other cells.

SIDS risk lowered by use of pacifier

The risk of Sudden Infant Death Syndrome (SIDS), the third leading cause of infant death, may be lowered through the use of a pacifier.

RRM2 may be a facilitating factor in colorectal cancer and UV-induced DNA damage repair

Study offers hope of early detection, treatment of liver cancer

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Leo Figgs is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Leo Figgs, DO 1410 Lakeside Ct Ste 103, Yakima, WA 98902-7305 Ph: (509) 453-2010	Dr Leo Figgs, DO 1410 Lakeside Ct Ste 103, Yakima, WA 98902-7305 Ph: (509) 453-2010

News Archive

Data of ImmunoCellular's lead dendritic cell cancer vaccine candidate for GBM presented at AAN meeting

Caltech researchers develop new technique that increases safety of TCR gene therapy

The human body produces T cells to recognize and fight disease. Each T cell has a unique T cell receptor (or TCR) on its surface that surveils small fragments of proteins presented by other cells.

SIDS risk lowered by use of pacifier

The risk of Sudden Infant Death Syndrome (SIDS), the third leading cause of infant death, may be lowered through the use of a pacifier.

RRM2 may be a facilitating factor in colorectal cancer and UV-induced DNA damage repair

Study offers hope of early detection, treatment of liver cancer

Ophthalmology Doctors in Yakima, WA

Richard Hansen Hopp, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3999 Englewood Ave # 101, Yakima, WA 98902 Phone: 509-452-2020 Fax: 509-452-8398
Mr. Richard E Ehlers, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3403 Powerhouse Rd, Yakima, WA 98902 Phone: 509-966-2253 Fax: 509-966-3768
Abel Li, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3902 Creekside Loop, Suite 110, Yakima, WA 98902 Phone: 509-452-6611 Fax: 509-248-0621

Dr Leo Figgs, DO - Medicare Ophthalmology in Yakima, WA

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

Data of ImmunoCellular's lead dendritic cell cancer vaccine candidate for GBM presented at AAN meeting

Caltech researchers develop new technique that increases safety of TCR gene therapy

SIDS risk lowered by use of pacifier

RRM2 may be a facilitating factor in colorectal cancer and UV-induced DNA damage repair

Study offers hope of early detection, treatment of liver cancer

Medicare Reassignments

Data of ImmunoCellular's lead dendritic cell cancer vaccine candidate for GBM presented at AAN meeting

Caltech researchers develop new technique that increases safety of TCR gene therapy

SIDS risk lowered by use of pacifier

RRM2 may be a facilitating factor in colorectal cancer and UV-induced DNA damage repair

Study offers hope of early detection, treatment of liver cancer

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Data of ImmunoCellular's lead dendritic cell cancer vaccine candidate for GBM presented at AAN meeting

Caltech researchers develop new technique that increases safety of TCR gene therapy

SIDS risk lowered by use of pacifier

RRM2 may be a facilitating factor in colorectal cancer and UV-induced DNA damage repair

Study offers hope of early detection, treatment of liver cancer

Ophthalmology Doctors in Yakima, WA